Abstract |
N-Succinyl-chitosan has favourable properties as a drug carrier, such as biocompatibility, low toxicity and long-term retention in the body. It is a good candidate for cancer chemotherapy as a polymeric drug carrier. This study describes the preparation and characterization of 5-fluorouracil-loaded N-succinyl-chitosan nanoparticles (5-FU-Suc-Chi/NP) by an emulsification solvent diffusion method. The influence of the initial 5-FU concentration on the nanoparticle characteristics and release behaviour in phosphate-buffered saline solution (PBS) was evaluated. The Suc-Chi nanoparticles had a particle diameter (Z-average) in the range 202 approximately 273 nm and a negative zeta-potential (approx. -27 to -18 mV). The formulation with an initial 5-FU concentration of 1000 microg mL-1 provided the highest loading capacity (19%) and the highest extent of release (61% at 24 h). The 5-FU-Suc-Chi/NP showed good anti-tumour activity against Sarcoma 180 solid tumour and mild toxicity. According to the data obtained, this Suc-Chi-based nanotechnology opens new and interesting perspectives for cancer chemotherapy.
|
Authors | Chengyun Yan, Dawei Chen, Jiwei Gu, Jing Qin |
Journal | The Journal of pharmacy and pharmacology
(J Pharm Pharmacol)
Vol. 58
Issue 9
Pg. 1177-81
(Sep 2006)
ISSN: 0022-3573 [Print] England |
PMID | 16945175
(Publication Type: Journal Article)
|
Chemical References |
- Antimetabolites, Antineoplastic
- Colloids
- Delayed-Action Preparations
- Drug Carriers
- N-succinyl-chitosan
- Chitosan
- Fluorouracil
|
Topics |
- Animals
- Antimetabolites, Antineoplastic
(chemistry, therapeutic use)
- Chitosan
(chemistry)
- Colloids
- Delayed-Action Preparations
- Diffusion
- Drug Carriers
- Drug Compounding
- Fluorouracil
(chemistry, therapeutic use)
- Mice
- Mice, Inbred BALB C
- Nanoparticles
- Neoplasm Transplantation
- Particle Size
- Sarcoma 180
(drug therapy, pathology)
- Solubility
- Time Factors
|